NCT07472907: A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 135 planned
- Started
- Jan 2027
- Primary completion
- Dec 2027
- Arms
- CIL001
- Results
- None posted
- 16 Mar 2026: Trial registered